All treatments
Treatment
Sodium Chloride 0.9% clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
This study is testing a new vaccine (mRNA-1647) to see if it can prevent cytomegalovirus (CMV) infection in healthy people. We want to know how well it works, if it's safe, and how a person's body reacts to it. The vaccine is given to adults aged 16 to 40.
For: Cytomegalovirus Infection (CMV)Finland · Italy · Spain - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Double-blind, Randomized, Active-control, Parallel Group Study to Assess the Pharmacokinetics, Pharmacodynamics, Immunogenicity, and safety of SAR447537 (INBRX-101) Compared to Plasma Derived Apha1-Proteinase Inhibitor (A1PI) Augmentation Therapy in Adults with Alpha-1 Antitrypsin Deficiency (AATD) Emphysema
This study compares a new medicine, INBRX-101, with standard treatment for Alpha-1 Antitrypsin Deficiency (AATD) emphysema. It looks at how the medicines work in the body, their effects, and if they are safe, to help people with this lung condition.
For: Alpha-1 Antitrypsin Deficiency (AATD) EmphysemaDenmark · Sweden · Ireland